Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2905 studies found for:    "Carcinoma, Non-Small-Cell Lung"
Show Display Options
Rank Status Study
21 Completed
Has Results
Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gefitinib retreatment
22 Recruiting Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Sym004 plus Platinum-Doublet Chemotherapy
23 Completed
Has Results
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Intervention: Drug: Tarceva (Erlotinib)
24 Completed Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)
Conditions: Non Small Cell Lung Carcinoma;   Metastatic Breast Cancer
Intervention:
25 Completed Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: neoadjuvant erlotinib therapy;   Drug: neoadjuvant gemcitabine/carboplatin therapy
26 Completed Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-small Cell Lung Cancer;   NSCLC
Interventions: Drug: Erlotinib (tarceva);   Drug: Placebo
27 Active, not recruiting Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Tecemotide;   Drug: Placebo;   Drug: Cyclophosphamide (CPA);   Drug: Saline (sodium chloride)
28 Recruiting Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Oshadi D and Oshadi R;   Drug: Docetaxel
29 Active, not recruiting A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MM-121 (SAR256212) + erlotinib;   Drug: Erlotinib
30 Completed
Has Results
BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Cancer;   Carcinoma, Non-Small Cell Lung
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
31 Recruiting Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Progression of Non-small Cell Lung Cancer;   Non-small Cell Lung Cancer Recurrent
Interventions: Drug: Docetaxel;   Biological: HyperAcute®-Lung Immunotherapy;   Drug: Gemcitabine;   Drug: Pemetrexed
32 Terminated Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: pemetrexed;   Drug: pemetrexed + PF-3512676
33 Recruiting Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)
Conditions: Non-small Cell Lung Cancer Stage I;   Non-small Cell Lung Cancer Stage II;   Non-small Cell Lung Cancer Stage IIIA
Intervention:
34 Withdrawn TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Bevacizumab
35 Terminated Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-3512676 + Paclitaxel + Carboplatin;   Drug: Paclitaxel + Carboplatin
36 Unknown  Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Endostatins;   Drug: Docetaxel
37 Completed Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Neoplasms
Intervention: Drug: MAC-321
38 Unknown  Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Stage IIIB;   Non-small Cell Lung Cancer Stage IV;   Non-small Cell Lung Cancer Metastatic
Interventions: Drug: Docetaxel;   Drug: Combination of ganetespib and docetaxel
39 Completed An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Neoplasm
Intervention: Biological: EP2101
40 Completed Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin, Ifosfamide, Gemcitabine;   Drug: Ifosfamide, Gemcitabine;   Drug: Cisplatin, docetaxel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years